TLR3 and HIV-1 infection: Moreover, the compound, either alone or in combination with TLR3 and TRL4 agonists, elicits the expression of cytokines, chemokines, and co-stimulatory molecules that are involved in counteracting HIV-1 infection, in activating and recruiting APCs, and in shaping adaptive immunity.